Engineered Bacillus subtilis for the de novo production of 2′-fucosyllactose
Abstract Background The most abundant human milk oligosaccharide in breast milk, 2′-fucosyllactose (2′-FL), has been approved as an additive to infant formula due to its multifarious nutraceutical and pharmaceutical functions in promoting neonate health. However, the low efficiency of de novo synthe...
שמור ב:
| Principais autores: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2022-06-01
|
| סדרה: | Microbial Cell Factories |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12934-022-01838-w |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
